These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 15140917

  • 1. Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background.
    Nally RE, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1281-7. PubMed ID: 15140917
    [Abstract] [Full Text] [Related]

  • 2. Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout'.
    Nally RE, McNamara FN, Clifford JJ, Kinsella A, Tighe O, Croke DT, Fienberg AA, Greengard P, Waddington JL.
    Neuropsychopharmacology; 2003 Dec; 28(12):2055-63. PubMed ID: 12865890
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout".
    McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Fuchs S, Croke DT, Waddington JL.
    Synapse; 2002 Oct; 46(1):19-31. PubMed ID: 12211095
    [Abstract] [Full Text] [Related]

  • 4. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
    O'Sullivan GJ, Kinsella A, Sibley DR, Tighe O, Croke DT, Waddington JL.
    Synapse; 2005 Mar 15; 55(4):201-11. PubMed ID: 15668951
    [Abstract] [Full Text] [Related]

  • 5. Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype.
    McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Croke DT, Waddington JL.
    Neuropsychopharmacology; 2003 Jan 15; 28(1):86-99. PubMed ID: 12496944
    [Abstract] [Full Text] [Related]

  • 6. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J, Cepeda C, Hernández-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine MS.
    J Neurophysiol; 2002 Dec 15; 88(6):3010-20. PubMed ID: 12466426
    [Abstract] [Full Text] [Related]

  • 7. Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions.
    O'Sullivan GJ, Kinsella A, Grandy DK, Tighe O, Croke DT, Waddington JL.
    Synapse; 2006 Feb 15; 59(2):107-18. PubMed ID: 16320306
    [Abstract] [Full Text] [Related]

  • 8. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
    Edwards S, Simmons DL, Galindo DG, Doherty JM, Scott AM, Hughes PD, Wilcox RE.
    Alcohol Clin Exp Res; 2002 Feb 15; 26(2):173-80. PubMed ID: 11964556
    [Abstract] [Full Text] [Related]

  • 9. Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice.
    Onn SP, Fienberg AA, Grace AA.
    J Pharmacol Exp Ther; 2003 Sep 15; 306(3):870-9. PubMed ID: 12805477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors.
    Håkansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G.
    J Neurochem; 2006 Jan 15; 96(2):482-8. PubMed ID: 16336634
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ, Caine SB.
    J Pharmacol Exp Ther; 2005 Feb 15; 312(2):733-41. PubMed ID: 15494551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
    Kuroiwa M, Hamada M, Hieda E, Shuto T, Sotogaku N, Flajolet M, Snyder GL, Hendrick JP, Fienberg A, Nishi A.
    Neuropharmacology; 2012 Dec 15; 63(7):1248-57. PubMed ID: 22971543
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.